Enhance your practice with CME and tools that focus on the management of neurological conditions.
Strategies to Safeguard Brain Health in MS
Christopher Lock, MD
The Burden of Cognitive Dysfunction in Multiple Sclerosis
Who’s Missing from Multiple Sclerosis Research?
Ashley Baker, MSN, PMHNP
Ruth Ann Marrie, MD, PhD
GFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
Understanding Accelerated Biological Aging in Pediatric MS
Jennifer Yang, MD
Multiple Sclerosis Without Borders: Taking a Global View
Andrew Wilner, MD, FACP, FAAN
Victor Rivera, MD
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
Adil Harroud, MD
Dylan Hamitouche
Ryan Quigley
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
Alexandria May, PharmD, BCPS
Apurva Bhatt, MD
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
March 23, 2026
March 23, 2026 Boston, Massachusetts
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026
May 27, 2026 Miami Beach, Florida
Miami Beach, Florida
New Pathways in the Treatment of DMD
Erika Finanger, MD, MS
Aravindhan Veerapandiyan, MD
CK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
Raphael Schneider, MD, PhD, FRCPC, CIP
Boston, Massachusetts
Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
Mike Sharma, MD, MSc, FRCPC
12:30 PM - 01:30 PM EDT
Evaluating Structured Interventions for Cognitive Support in MS
Hallie Blevins, PhD
Optimizing Vitamin D Supplementation in MS Care
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.